1.4101
Schlusskurs vom Vortag:
$1.44
Offen:
$1.44
24-Stunden-Volumen:
348.72K
Relative Volume:
0.60
Marktkapitalisierung:
$1.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-20.26M
KGV:
-0.1651
EPS:
-8.54
Netto-Cashflow:
$-8.25M
1W Leistung:
-0.28%
1M Leistung:
-60.50%
6M Leistung:
-84.52%
1J Leistung:
-95.52%
Oragenics Inc Stock (OGEN) Company Profile
Firmenname
Oragenics Inc
Sektor
Branche
Telefon
813-286-7900
Adresse
4902 Eisenhower Boulevard, Suite 125, Tampa, FL
Vergleichen Sie OGEN mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OGEN
Oragenics Inc
|
1.4394 | 1.14M | 0 | -20.26M | -8.25M | -8.54 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
473.41 | 120.73B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
564.71 | 60.56B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
329.06 | 42.41B | 2.35B | -269.70M | -75.39M | -2.09 |
![]()
ARGX
Argen X Se Adr
|
589.38 | 34.96B | 2.58B | 1.06B | -1.28B | 16.33 |
![]()
ONC
Beone Medicines Ltd Adr
|
296.02 | 31.99B | 3.81B | -644.79M | -669.77M | -6.24 |
Oragenics Inc Aktie (OGEN) Neueste Nachrichten
What drives Oragenics Inc. stock priceSuperior capital gains - Autocar Professional
Oragenics Inc. Stock Analysis and ForecastExceptional return forecasts - Autocar Professional
What analysts say about Oragenics Inc. stockOutstanding stock performance - Autocar Professional
Is Oragenics Inc. a good long term investmentPhenomenal returns - jammulinksnews.com
Why Oragenics Inc. stock attracts strong analyst attention5x Profit Potential - Newser
Oragenics Announces Approval of Common Stock Listing on NYSE MKT - AOL.com
Oragenics Partners With Sterling For U.S.-Based Manufacturing Of Concussion Drug ONP-002 - Nasdaq
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials - citybuzz -
Oragenics, Inc. Announces U.S.-Based Drug Manufacturing Agreement to Support ONP-002 Clinical Development - The Manila Times
Oragenics partners with Sterling for concussion drug production By Investing.com - Investing.com South Africa
Oragenics partners with Sterling for concussion drug production - Investing.com
What makes Oragenics Inc. stock price move sharplyHigh Probability Setups - Newser
How Oragenics Inc. stock performs during market volatilityFree Real-Time Market Predictions - Newser
Best Momentum Stock to Buy for July 7th - The Globe and Mail
Oragenics Soars 11.11% on $20M Capital Raise for Clinical Trials - AInvest
Oragenics Closes $16.5 Million Offering of Preferred Stock, Warrants - MarketScreener
Oragenics Raises $16.5M Through Public Offering - TipRanks
Oragenics, Inc. Successfully Closes $16.5 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics' Stock Takes A Hit With New Offering Announcement - Finimize
Form 424B5 ORAGENICS INC - StreetInsider
Oragenics shares plunge following announcement of $20 million preferred stock sale - MSN
Oragenics Inc. Announces $20 Million Preferred Stock and Warrant Offering to Fund Concussion Trials and R&D - citybuzz -
Oragenics stock tumbles after announcing $20 million preferred stock offering - Investing.com
Why Is Oragenics Stock (OGEN) Down 55% Today? - TipRanks
Oragenics announces $20 million preferred stock offering - Investing.com Australia
Oragenics, Inc. Announces $20 Million Public Offering of Series H Convertible Preferred Stock and Warrants - Nasdaq
Oragenics announces $20 million preferred stock offering By Investing.com - Investing.com UK
Oragenics, Inc. Announces Pricing of Public Offering of up to $20 Million of Preferred Stock and Warrants - TradingView
Major Shareholder Odyssey Health Sells Oragenics Stock! - TipRanks
Future of Oral Probiotic Supplements | Innovations in Oral - openPR.com
Oragenics Inc. to Showcase Concussion Treatment Candidate at Major 2025 Conferences - citybuzz -
Oragenics to Present at 2025 BIO International Convention and At - GuruFocus
Oragenics, Inc. to Present ONP-002 at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - Nasdaq
GlobeNewswire by Notified - The Manila Times
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium | OGEN Stock News - GuruFocus
Oragenics to Present at 2025 BIO International Convention and Attend 42nd Annual National Neurotrauma Society Symposium - The Manila Times
Pre-market Movers: EVGN, WINT, CARM, UNCY... - RTTNews
Oragenics to Present at 2025 BIO International Convention - GlobeNewswire
Finanzdaten der Oragenics Inc-Aktie (OGEN)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):